digital
23andMe and its user data will soon belong to a pharmaceutical giant
Regeneron Pharmaceuticals is acquiring “substantially all of” 23andMe’s assets. 23andMe will keep offering customers its DNA testing services after being bought out of bankruptcy. New York-based biotech company Regeneron Pharmaceuticals announced an agreement on Monday Read more…